Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

Core Viewpoint - Spero Therapeutics, Inc. will report its financial results for Q4 and the full year of 2025 on March 26, 2026, after market close, and will not host a conference call [1]. Company Overview - Spero Therapeutics is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing novel treatments for rare diseases and conditions with high unmet medical needs [2].